Research led by Monash University has found that a commonly used diabetes medicine can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements.
Repurposed diabetes drug could deliver gains for people living with major joint pain
April 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - -
Radiopharm Theranostics doses first patient in US Phase 2b imaging study of brain metastasis
April 28, 2025 - - Australian Biotech -
Dimerix says FDA confirms proteinuria as acceptable endpoint for DMX-200 Phase 3 trial
April 28, 2025 - - Australian Biotech -
Government funding for new nasal spray ends three-decade drought
April 27, 2025 - - Latest News -
Repurposed diabetes drug could deliver gains for people living with major joint pain
April 27, 2025 - - Latest News -
March PBAC delivers outcome for high profile pre-funded cancer therapy
April 27, 2025 - - Latest News -
TGA approves new indication for GSK's RSV vaccine
April 24, 2025 - - Latest News